Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | FAAH | O00519 | 2/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.62 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | ADH1B | P00325 | 1/20 | 0.52 |
| ▸ | ADH1C | P00326 | 1/20 | 0.52 |
| ▸ | ADH1A | P07327 | 1/20 | 0.52 |
| ▸ | ADH4 | P08319 | 1/20 | 0.52 |
| ▸ | ADH7 | P40394 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9480001 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL518802 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL9208641 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL6677501 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL519455 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL11786437 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL518800 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL554166 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL22063916 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL296807 | 1.00 | TSHR (0.65) | TSHRALDH1A1FAAHTRPV1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12285525-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-116172975-B | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-114728016-B | Lipid composition | 富士胶片株式会社 | 2024-10-29 | — | — | CN | disclosed |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| CN-113924128-B | Lipid composition | 富士胶片株式会社 | 2024-09-06 | — | — | CN | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-20220273817-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| EP-3981435-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-04-13 | — | — | EP | disclosed |
| US-20220096381-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| CN-113924128-A | Lipid composition | 富士胶片株式会社 | 2022-01-11 | — | — | CN | disclosed |
| EP-3805198-A1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-3805198-A1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| CN-112262122-A | Compound or salt thereof, and lipid particle | 富士胶片株式会社 | 2021-01-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | TSHR 999/4885ALDH1A1 2243/4885FAAH 1917/4885 |
| US-12285525-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | TSHR 999/4885ALDH1A1 2243/4885FAAH 1917/4885 |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | TSHR 999/4885ALDH1A1 2243/4885FAAH 1917/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | TSHR 1103/4885ALDH1A1 2418/4885FAAH 3106/4885 |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | TSHR 984/4885ALDH1A1 2368/4885FAAH 1937/4885 |
| US-20220273817-A1 | LIPID COMPOSITION | NR1H3, NR1H2, NR1H4 | TSHR 627/4885ALDH1A1 2683/4885FAAH 1589/4885 |
| US-20220096381-A1 | LIPID COMPOSITION | NR1H3, NR1H4, NR1H2 | TSHR 814/4885ALDH1A1 3097/4885FAAH 1485/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | TSHR 1216/4885ALDH1A1 2907/4885FAAH 1313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.